IPSC

NASD Century Therapeutics, Inc.
Oct 21, 2026 · 5:49 PM ET LAST TRADE Market Closed

$1.61 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.61, $0.06 below the day’s high of $1.67

YTD change
+61.84%
vs 20-day SMA
+5.64%
vs 200-day SMA
-23.39%

Price ranges

Previous day
$1.40 $1.75
open $1.49 close $1.64
+$0.15 (+10.07%)
Today
$1.53 $1.67
open $1.65 now $1.61
-$0.04 (-2.42%)
Past week
$1.31 $1.75
from $1.38 now $1.61
+$0.23 (+16.67%)
Past month
$1.22 $1.94
from $1.89 now $1.61
-$0.28 (-14.81%)
This year
$0.90 $3.04
from $0.99 now $1.61
+$0.62 (+61.84%)

Price & Performance

-0.66 (-28.70%) / 6M

$1.19$1.64$2.09$2.54Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 95.1% away from all-time highs of $32.90
  • IPSC is up 62% since the beginning of the year
  • IPSC is up 185% over the past 12 months
  • IPSC is down 15% over the past 1 month
  • 17% of all IPSC investors are betting against IPSC

IPSC reads neutral: price sits above one of the two key moving averages, the 12-month move is +190.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.17
Earnings momentum -41.7% Quarterly EPS growth
Quarterly change -41.7%

Valuation

P/E ratio N/A
Enterprise value $256.4M
Beta 2.53

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$119.7M
Debt$38.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $329.6M

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.94 +3.29%
MRNA Moderna, Inc. $242.08 +6.69%
RVMD Revolution Medicines, Inc. $196.55 +7.91%
ROIV Roivant Sciences Ltd. $34.92 +0.63%
BNTX BioNTech SE Sponsored ADR $91.17 +2.20%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.